Andreas D. Koutselos

Andreas D. Koutselos

Auto-generated profile, based on publicly available information

Andreas D. Koutselos

Department of Chemistry, Physical Chemistry Laboratory, National and Kapodistrian University of Athens, Panepistimiopolis, Athens 15771, Greece

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2015 in The Journal of Physical Chemistry A
Verified
Journal Article
Closed access
ILIraklis Litinas
Iraklis Litinas
AKAndreas D. Koutselos
Andreas D. Koutselos

16 May 2011 in The Journal of Chemical Physics
Verified
Journal Article
Closed access
AKAndreas D. Koutselos
Andreas D. Koutselos
Ion transport and dynamic properties are calculated through molecular dynamics simulation of the motion of O2+ in Kr under the action of an electrostatic field. The two lower potential energy surfaces X̃2A″ and Ã2A′ are considered for the interaction of the Π ground state of the ion with a closed shell noble gas. First, we study the reproduction of experimental mobility data through the use of single and multiple potential energy surfaces and establish the contribution of both lower energy states to the interactions. Further, we obtain mean energies and components of the diffusion coefficient parallel and perpendicular to the field, the latter through calculation of the velocity correlation functions. We also calculate components of the angular momentum which provide a measure of the collisional rotational alignment of the ions at high field strength.

18 June 2024 in Journal of Chemical Information and Modeling
Verified
Journal Article
Open access
IDIsidora Diakogiannaki
Isidora Diakogiannaki
MPMichail Papadourakis
Michail Papadourakis
VSVasileia Spyridaki
Vasileia Spyridaki
ZCZoe Cournia
Zoe Cournia
AKAndreas Koutselos
Andreas Koutselos
Beta-N-methylamino-l-alanine (BMAA) is a potential neurotoxic nonprotein amino acid, which can reach the human body through the food chain. When BMAA interacts with bicarbonate in the human body, carbamate adducts are produced, which share a high structural similarity with the neurotransmitter glutamate. It is believed that BMAA and its l-carbamate adducts bind in the glutamate binding site of ionotropic glutamate receptor 2 (GluR2). Chronic exposure to BMAA and its adducts could cause neurological illness such as neurodegenerative diseases. However, the mechanism of BMAA action and its carbamate adducts bound to GluR2 has not yet been elucidated. Here, we investigate the binding modes and the affinity of BMAA and its carbamate adducts to GluR2 in comparison to the natural agonist, glutamate, to understand whether these can act as GluR2 modulators. Initially, we perform molecular dynamics simulations of BMAA and its carbamate adducts bound to GluR2 to examine the stability of the ligands in the S1/S2 ligand-binding core of the receptor. In addition, we utilize alchemical free energy calculations to compute the difference in the free energy of binding of the beta-carbamate adduct of BMAA to GluR2 compared to that of glutamate. Our findings indicate that carbamate adducts of BMAA and glutamate remain stable in the binding site of the GluR2 compared to BMAA. Additionally, alchemical free energy results reveal that glutamate and the beta-carbamate adduct of BMAA have comparable binding affinity to the GluR2. These results provide a rationale that BMAA carbamate adducts may be, in fact, the modulators of GluR2 and not BMAA itself.

4 June 2019 in The Journal of Physical Chemistry A
Verified
Journal Article
Closed access
ILIraklis Litinas
Iraklis Litinas
AKAndreas D. Koutselos
Andreas D. Koutselos

15 January 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
IDIsidora Diakogiannaki
Isidora Diakogiannaki
MPMichail Papadourakis
Michail Papadourakis
VSVasileia Spyridaki
Vasileia Spyridaki
ZCZoe Cournia
Zoe Cournia
AKAndreas Koutselos
Andreas Koutselos
Beta-N-methylamino-L-alanine (BMAA) is a potential neurotoxic non-protein amino acid, which can reach the human body through the food chain. When BMAA interacts with bicarbonate in the human body, carbamate adducts are produced, which share high structural similarity with the neurotransmitter glutamate. It is believed that BMAA and its L-carbamate adducts bind in the glutamate binding site of ionotropic glutamate receptor 2 (GluR2). Chronic exposure to BMAA and its adducts could cause neurological illness such as neurodegenerative diseases. However, the mechanism of BMAA action and its carbamate adducts bound to GluR2 has not been yet elucidated. Here, we investigate the binding modes and the affinity of BMAA and its carbamate adducts to GluR2 in comparison to the natural agonist, glutamate, to understand whether these can act as GluR2 agonists. Initially, we perform Molecular Dynamics (MD) simulations of BMAA and its carbamate adducts bound to GluR2 to examine the stability of the ligands in the S1/S2 ligand-binding domain of the receptor. In addition, we perform alchemical free energy calculations to compute the difference in the free energy of binding of the beta-carbamate adduct of BMAA to GluR2 compared to glutamate. Our findings indicate that carbamate adducts of BMAA and glutamate remain stable in the binding site of the GluR2 compared to BMAA. Additionally, alchemical free energy results reveal that glutamate and the beta-carbamate adduct of BMAA have comparable binding affinity in the GluR2. These results provide a rationale that BMAA carbamate adducts may be in fact the modulators of GluR2 and not BMAA itself.